Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies Current Ratio 2013-2019 | ITCI

Intra-Cellular Therapies current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Intra-Cellular Therapies Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.26B $0.03B 7.77
2019-06-30 $0.29B $0.03B 8.87
2019-03-31 $0.32B $0.03B 9.59
2018-12-31 $0.36B $0.04B 9.79
2018-09-30 $0.38B $0.03B 13.16
2018-06-30 $0.41B $0.02B 21.64
2018-03-31 $0.44B $0.02B 22.55
2017-12-31 $0.47B $0.01B 33.02
2017-09-30 $0.33B $0.01B 28.08
2017-06-30 $0.35B $0.01B 50.10
2017-03-31 $0.37B $0.02B 22.77
2016-12-31 $0.39B $0.01B 36.86
2016-09-30 $0.54B $0.14B 3.85
2016-06-30 $0.45B $0.02B 23.05
2016-03-31 $0.46B $0.01B 51.74
2015-12-31 $0.48B $0.01B 77.15
2015-09-30 $0.51B $0.01B 49.32
2015-06-30 $0.21B $0.01B 22.82
2015-03-31 $0.24B $0.02B 16.21
2014-12-31 $0.13B $0.01B 12.41
2014-09-30 $0.14B $0.00B 38.43
2014-06-30 $0.14B $0.00B 51.55
2014-03-31 $0.15B $0.00B 37.42
2013-12-31 $0.04B $0.01B 5.60
2013-09-30 $0.05B $0.01B 6.06
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.16
2012-12-31 $0.00B 0.00
2012-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.266B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.810B 15.07
CSL (CSLLY) Australia $100.765B 0.00
Gilead Sciences (GILD) United States $85.473B 11.00
Vertex Pharmaceuticals (VRTX) United States $63.215B 57.37
Biogen (BIIB) United States $57.963B 9.90
Regeneron Pharmaceuticals (REGN) United States $43.958B 18.62
Illumina (ILMN) United States $43.941B 45.43
Alexion Pharmaceuticals (ALXN) United States $22.707B 10.56
Seattle Genetics (SGEN) United States $20.339B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.638B 0.00
Incyte (INCY) United States $17.006B 36.49
BioMarin Pharmaceutical (BMRN) United States $15.988B 0.00
Genmab (GNMSF) Denmark $14.741B 65.11
Alnylam Pharmaceuticals (ALNY) United States $14.490B 0.00
Galapagos (GLPG) Belgium $14.198B 36.58
Exact Sciences (EXAS) United States $12.747B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.078B 56.43
BeiGene (BGNE) Cayman Islands $10.449B 0.00
Sarepta Therapeutics (SRPT) United States $9.349B 0.00
QIAGEN (QGEN) Netherlands $8.375B 25.79
Bio-Techne Corp (TECH) United States $7.997B 54.73
Guardant Health (GH) United States $7.916B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.099B 0.00
BioNTech SE (BNTX) Germany $6.958B 0.00
Reata Pharmaceuticals (RETA) United States $6.831B 0.00
Ascendis Pharma (ASND) Denmark $6.732B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.730B 17.11
Moderna (MRNA) United States $6.394B 0.00
Exelixis (EXEL) United States $6.311B 17.75
Amarin (AMRN) Ireland $6.294B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.105B 0.00
Repligen (RGEN) United States $5.517B 99.97
Acceleron Pharma (XLRN) United States $4.972B 0.00
Bluebird Bio (BLUE) United States $4.942B 0.00
China Biologic Products (CBPO) China $4.597B 25.89
Adaptive Biotechnologies (ADPT) United States $3.913B 0.00
MorphoSys AG (MOR) Germany $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.635B 0.00
Blueprint Medicines (BPMC) United States $3.619B 0.00
NeoGenomics (NEO) United States $3.569B 189.89
Immunomedics (IMMU) United States $3.550B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.539B 0.00
Zai Lab (ZLAB) China $3.517B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.395B 57.53
Emergent Biosolutions (EBS) United States $3.261B 32.40
MyoKardia (MYOK) United States $3.254B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.157B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.104B 0.00
Halozyme Therapeutics (HALO) United States $3.092B 0.00
Genmab (GMAB) Denmark $3.074B 6.33
Alkermes (ALKS) Ireland $2.804B 222.13
Amicus Therapeutics (FOLD) United States $2.798B 0.00
UniQure (QURE) Netherlands $2.756B 0.00
Insmed (INSM) United States $2.737B 0.00
Arena Pharmaceuticals (ARNA) United States $2.706B 6.29
Denali Therapeutics (DNLI) United States $2.441B 0.00
Epizyme (EPZM) United States $2.209B 0.00
RA PHARMCTL INC (RARX) United States $2.201B 0.00
Fate Therapeutics (FATE) United States $2.183B 0.00
Principia Biopharma (PRNB) United States $2.120B 0.00
Alector (ALEC) United States $2.068B 0.00
REGENXBIO (RGNX) United States $1.980B 0.00
Zymeworks (ZYME) Canada $1.889B 0.00
Ligand Pharmaceuticals (LGND) United States $1.708B 49.86
Arvinas (ARVN) United States $1.698B 0.00
Akcea Therapeutics (AKCA) United States $1.686B 0.00
Zealand Pharma (ZEAL) Denmark $1.595B 0.00
Coherus BioSciences (CHRS) United States $1.525B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.456B 0.00
Myriad Genetics (MYGN) United States $1.448B 25.55
Editas Medicine (EDIT) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.212B 0.00
Athenex (ATNX) United States $1.206B 0.00
PHARMA MAR SA (PHMMF) Spain $1.184B 0.00
Revance Therapeutics (RVNC) United States $1.143B 0.00
Twist Bioscience (TWST) United States $1.070B 0.00
Adverum Biotechnologies (ADVM) United States $1.020B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.014B 0.00
Mesoblast (MESO) Australia $0.948B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.878B 0.00
Cytokineticsorporated (CYTK) United States $0.877B 0.00
DBV Technologies S.A (DBVT) France $0.861B 0.00
Vericel (VCEL) United States $0.852B 317.83
Codexis (CDXS) United States $0.821B 0.00
Heska (HSKA) United States $0.807B 206.14
ANI Pharmaceuticals (ANIP) United States $0.794B 13.54
Cellectis S.A (CLLS) France $0.742B 0.00
Retrophin (RTRX) United States $0.712B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
Intrexon (PGEN) United States $0.695B 0.00
GENFIT S.A (GNFT) France $0.694B 0.00
Intellia Therapeutics (NTLA) United States $0.678B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.677B 5.70
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
NantKwest (NK) United States $0.620B 0.00
Anika Therapeutics (ANIK) United States $0.592B 19.20
UROGEN PHARMA (URGN) United States $0.586B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.576B 0.00
AC Immune SA (ACIU) Switzerland $0.576B 13.31
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.538B 0.00
Prothena (PRTA) Ireland $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Arcus Biosciences (RCUS) United States $0.506B 0.00
Agenus (AGEN) United States $0.503B 0.00
Bellus Health (BLU) Canada $0.493B 0.00
Puma Biotechnology (PBYI) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.472B 0.00
Compugen (CGEN) Israel $0.463B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Sorrento Therapeutics (SRNE) United States $0.456B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.449B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.437B 0.00
Merus (MRUS) Netherlands $0.436B 0.00
Dynavax Technologies (DVAX) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.421B 0.00
Inovio Pharmaceuticals (INO) United States $0.421B 0.00
Precision BioSciences (DTIL) United States $0.420B 0.00
PDL BioPharma (PDLI) United States $0.419B 10.49
AnaptysBio (ANAB) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.399B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.373B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.345B 0.00
Gritstone Oncology (GRTS) United States $0.339B 0.00
Syros Pharmaceuticals (SYRS) United States $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Albireo Pharma (ALBO) United States $0.314B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.308B 2.13
AMAG Pharmaceuticals (AMAG) United States $0.302B 0.00
MannKind (MNKD) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.290B 0.00
Kamada (KMDA) Israel $0.290B 12.06
WAVE Life Sciences (WVE) Singapore $0.277B 0.00
IVERIC Bio (ISEE) United States $0.273B 0.00
VBI Vaccines (VBIV) United States $0.273B 0.00
Aduro Biotech (ADRO) United States $0.272B 0.00
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
OSMOTICA PHARM (OSMT) United States $0.264B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.264B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.260B 0.00
Geron (GERN) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
Novavax (NVAX) United States $0.247B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
ChromaDex (CDXC) United States $0.244B 0.00
Kala Pharmaceuticals (KALA) United States $0.239B 0.00
XOMA (XOMA) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.222B 0.00
Prometic Life Sciences (LMNL) Canada $0.221B 0.00
Theratechnologies (THTX) Canada $0.215B 0.00
Alcobra (ARCT) United States $0.210B 0.00
Fortress Biotech (FBIO) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.208B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.205B 0.00
Exicure (XCUR) United States $0.205B 0.00
Cerecor (CERC) United States $0.201B 0.00
Athersys (ATHX) United States $0.194B 0.00
Affimed (AFMD) Germany $0.193B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.192B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Strongbridge Biopharma (SBBP) United States $0.178B 4.77
Spero Therapeutics (SPRO) United States $0.172B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Five Prime Therapeutics (FPRX) United States $0.165B 0.00
Abeona Therapeutics (ABEO) United States $0.162B 0.00
VTv Therapeutics (VTVT) United States $0.157B 0.00
Selecta Biosciences (SELB) United States $0.157B 0.00
Dyadic (DYAI) United States $0.154B 0.00
Aptinyx (APTX) United States $0.152B 0.00
Verastem (VSTM) United States $0.149B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.137B 0.00
ARAVIVE, INC (ARAV) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.124B 0.00
Happiness Biotech Group (HAPP) China $0.119B 0.00
Arsanis (XFOR) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.115B 0.00
Clearside Biomedical (CLSD) United States $0.112B 0.00
OvaScience (MLND) United States $0.107B 0.00
Enzo Biochem (ENZ) United States $0.106B 0.00
Prima BioMed (IMMP) Australia $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Applied Genetic Technologies (AGTC) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Emmaus Life Sciences (EMMA) United States $0.090B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.087B 0.00
Acorda Therapeutics (ACOR) United States $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 5.08
Synlogic (SYBX) United States $0.078B 0.00
Trevena (TRVN) United States $0.072B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
China Health Industries Holdings (CHHE) China $0.058B 17.78
NewLink Genetics (NLNK) United States $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Organovo Holdings (ONVO) United States $0.043B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
VIVUS (VVUS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.025B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00